ITB-Med

Organization

Trials

  • NCT06972069

    Collaborator, Early phase 1, Active, not recruiting, 12 people, May 14, 2025

  • NCT06365437

    Phase 2, Terminated, 33 people, Apr 15, 2024

  • NCT06078696

    Collaborator, Phase 1/2, Terminated, 1 person, Oct 12, 2023

  • NCT06019507

    Phase 2, Active, not recruiting, 12 people, Aug 31, 2023

  • NCT05900401

    Collaborator, Phase 1/2, Recruiting, 20 people, Jun 12, 2023

  • NCT05669001

    Phase 2, Completed, 76 people, Dec 30, 2022

  • NCT04311632

    Phase 2, Completed, 13 people, Mar 17, 2020